RhumbLine Advisers’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.2M Sell
67,471
-4,736
-7% -$1.49M 0.02% 680
2025
Q1
$22M Sell
72,207
-1,113
-2% -$339K 0.02% 641
2024
Q4
$24.4M Buy
73,320
+581
+0.8% +$193K 0.02% 598
2024
Q3
$24.3M Buy
72,739
+2,739
+4% +$914K 0.02% 604
2024
Q2
$28.8M Buy
70,000
+2,046
+3% +$843K 0.03% 500
2024
Q1
$27.5M Sell
67,954
-2,935
-4% -$1.19M 0.03% 552
2023
Q4
$21.7M Sell
70,889
-1,910
-3% -$585K 0.02% 634
2023
Q3
$17.6M Sell
72,799
-2,734
-4% -$662K 0.02% 689
2023
Q2
$18.1M Sell
75,533
-5,538
-7% -$1.33M 0.02% 699
2023
Q1
$15.2M Sell
81,071
-548
-0.7% -$103K 0.02% 747
2022
Q4
$17.3M Buy
81,619
+994
+1% +$211K 0.02% 660
2022
Q3
$12.7M Sell
80,625
-660
-0.8% -$104K 0.02% 769
2022
Q2
$12.2M Buy
81,285
+2,530
+3% +$379K 0.02% 806
2022
Q1
$12.9M Buy
78,755
+1,827
+2% +$299K 0.02% 833
2021
Q4
$16.7M Buy
76,928
+496
+0.6% +$108K 0.02% 707
2021
Q3
$14.5M Buy
76,432
+1,977
+3% +$374K 0.02% 757
2021
Q2
$13.2M Sell
74,455
-194
-0.3% -$34.3K 0.02% 842
2021
Q1
$12.2M Sell
74,649
-2,658
-3% -$436K 0.02% 867
2020
Q4
$10.8M Buy
77,307
+994
+1% +$138K 0.01% 870
2020
Q3
$8.53M Sell
76,313
-7,183
-9% -$803K 0.01% 854
2020
Q2
$7.77M Sell
83,496
-4,886
-6% -$455K 0.01% 912
2020
Q1
$6.49M Buy
88,382
+1,476
+2% +$108K 0.01% 878
2019
Q4
$7.31M Buy
86,906
+5,561
+7% +$467K 0.01% 1030
2019
Q3
$6.84M Buy
81,345
+3,813
+5% +$320K 0.01% 1009
2019
Q2
$5.07M Buy
77,532
+7,904
+11% +$517K 0.01% 1189
2019
Q1
$4.11M Buy
69,628
+2,209
+3% +$130K 0.01% 1290
2018
Q4
$3.57M Buy
67,419
+48,360
+254% +$2.56M 0.01% 1302
2018
Q3
$1.14M Buy
19,059
+7,379
+63% +$442K ﹤0.01% 1949
2018
Q2
$502K Buy
11,680
+2,049
+21% +$88.1K ﹤0.01% 2315
2018
Q1
$336K Buy
9,631
+1,005
+12% +$35.1K ﹤0.01% 2382
2017
Q4
$313K Sell
8,626
-1,312
-13% -$47.6K ﹤0.01% 2451
2017
Q3
$317K Buy
9,938
+212
+2% +$6.76K ﹤0.01% 2532
2017
Q2
$282K Buy
9,726
+1,140
+13% +$33.1K ﹤0.01% 2587
2017
Q1
$256K Buy
8,586
+312
+4% +$9.3K ﹤0.01% 2575
2016
Q4
$298K Buy
+8,274
New +$298K ﹤0.01% 2497